RND Short Volume
First Trust Bloomberg R&D Leaders ETF (RND) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $3.2M, listed on AMEX, carrying a beta of 1.24 to the broader market. The First Trust Bloomberg R&D Leaders ETF (the "Fund") seeks investment results that correspond generally to the price and yield (before the Fund's fees and expenses) of an index called the Bloomberg R&D Leaders Select Index (the "Index"). public since 2024-05-01.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-01
- Short Volume
- 105
- Total Volume
- 138
- Short %
- 76.09%
- 30-Day Avg Short %
- 73.44%
Showing 30 days of FINRA short volume data for First Trust Bloomberg R&D Leaders ETF.
Learn how short volume is reported and how to read the data →
Frequently asked RND short volume questions
- What is the daily RND short volume?
- As of Jun 1, 2026, First Trust Bloomberg R&D Leaders ETF (RND) short volume is 105 shares against 138 total reported volume, or 76.09% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is RND short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does RND short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.